Development of New Therapies
All evenings have the same arrangement:
19h00: Welcome
19h30: Introduction and lectures
21h30: Closing remarks and networking reception
Session Chair: Dr. Jérôme Van Biervliet (VIB - Managing Director)
Neurosciences and (rare?) diseases
Prof. dr. Rosa Rademaekers - Center for Molecular Neurology- UAntwerp
Pharma shifts: How to organise for Personal Medicines?
Ir. Bart Van Waeyenberge – EU CAR-T Program Lead, Board of Directors Janssen Pharmaceutica NV
From basic enzymology to new medicines
Prof. dr. Chris Schofield - Dep. Chemistry - University of Oxford
More information here.